Home/Filings/4/0000899243-17-014456
4//SEC Filing

INFINITY PHARMACEUTICALS, INC. 4

Accession 0000899243-17-014456

CIK 0001113148operating

Filed

May 25, 8:00 PM ET

Accepted

May 26, 8:19 AM ET

Size

7.9 KB

Accession

0000899243-17-014456

Insider Transaction Report

Form 4
Period: 2017-05-25
Transactions
  • Award

    Stock Option (right to buy)

    2017-05-25+20,00020,000 total
    Exercise: $1.74Exp: 2027-05-25Common Stock (20,000 underlying)
  • Award

    Stock Option (right to buy)

    2017-05-25+4,0004,000 total
    Exercise: $1.74Exp: 2027-05-25Common Stock (4,000 underlying)
Footnotes (2)
  • [F1]The option vests over a period of one year in equal quarterly installments beginning at the end of the first quarter after the date of grant, provided that the holder continues to serve as a director of the issuer.
  • [F2]The option vests over a period of one year in equal quarterly installments beginning at the end of the first quarter after the date of grant, provided that the holder continues to serve as Chair of the Research and Development Committee of the issuer's Board of Directors.

Issuer

INFINITY PHARMACEUTICALS, INC.

CIK 0001113148

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001113148

Filing Metadata

Form type
4
Filed
May 25, 8:00 PM ET
Accepted
May 26, 8:19 AM ET
Size
7.9 KB